The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.
about
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentagesPositive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic featuresSurgical treatment of pancreatic head cancer: concept revolutions and argumentsPancreatic cancer: Open or minimally invasive surgery?Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.Pancreatic cancer-improved care achievableNeoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.Pancreatic surgery: evolution and current tailored approachReduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancer.Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic functionStereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.Current state of surgical management of pancreatic cancer.Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective StudyTotal mesopancreas excision for pancreatic head cancer: analysis of 120 casesDefinition of microscopic tumor clearance (r0) in pancreatic cancer resections.Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinomaEn bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.Current adjuvant therapeutic approaches for pancreatic cancer.Mesopancreas in pancreatic cancer: where do we stand - review of literatureRedefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Mesopancreas is a misnomer: time to correct the nomenclature.Total meso-pancreatoduodenum excision with pancreaticoduodenectomy in lower biliary tract cancer.Location of the meso-pancreatoduodenum as a regional lymphatic basin for pancreatic head carcinoma.Arterial resection for pancreatic cancer: a modern surgeon should change its behavior according to the new therapeutic options.Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.[Prediction of prognosis of pancreatic cancer based on the homing area].Total mesopancreas excision for the treatment of pancreatic head cancer.Surgical margins for duodenopancreatectomy.Top-down approach to the superior mesenteric artery and the mesopancreas during pancreatoduodenectomy for pancreatic cancer.[R1 resection for pancreatic carcinoma].[New S3 guidelines on exocrine pancreatic cancer].
P2860
Q21092323-D7948576-6488-4BEA-9E68-9D4E5A8F8BA9Q26739915-8618BB33-B2A3-471F-B7CC-7102C1D265D0Q26781535-994C6183-6035-4794-A732-79B443C4673AQ28076803-89779ACB-AFFB-4502-BB7F-2043C795C6BCQ33916974-1EA6152E-D95F-41CB-BA86-947C070901F3Q34036659-DEFDE088-20A5-486F-8D06-4E952516E50BQ34183257-BC746B73-2671-4AF6-9507-05CCD7062144Q34395976-D8F05EB0-F0E2-4072-8AA1-A4DBF304F910Q34566032-D3E7BCC0-063A-4367-A6F5-064FDD000932Q35174270-2C230EC8-F56B-448C-B118-A01868B1528CQ36715792-90C0BE02-ECA1-4150-A39B-7A4F742A201BQ37129872-798EA1B6-33B3-43FC-973B-510DB625664DQ37204959-1FABAEF9-A65F-447E-9117-5410F6A99E9CQ37246941-B484559B-1866-4AFF-A654-41317A120BD9Q37342765-A893DB75-DD7D-41A5-B572-C8786322F64EQ37480826-A164340E-0C62-4CB5-BC02-226CBC7C8BD3Q37702608-FFD0DDAD-4545-4E0C-89DF-A0FABBEA0461Q37722157-21789A03-CF1E-4FC7-AABA-83A0121D17B5Q38321245-5017B875-95E9-4F6F-959C-CD49C2735D34Q38456837-FB60DEC0-02C3-4B2F-99BE-401E9EF58A8EQ38927638-6DA818D6-E0EC-4AD3-9664-368B813F823BQ38979371-B2747835-4051-4B8A-8FE9-68165E49E6D0Q39832491-A81D5240-5791-4F53-86A6-B9E99233AC14Q40978122-48D50A32-ED95-425F-AC34-FE16D81ABB3DQ43138752-453D443F-50B0-4273-B326-DEAF4BD88690Q43183747-BE5BFF71-2E8F-4309-A49C-E2397E4E0A83Q43825007-FCE9A63A-C9FF-46DA-89EA-6F49DF584965Q47126340-575E8650-58A8-4DB5-B11C-585B1BE7B8B9Q48278023-193BB6B8-A731-4186-9444-5D6746D03AD3Q52984795-9834BC10-BC80-43E6-B42D-9E7C87BEADDBQ53194479-0F086F4D-B579-4D65-B328-F25251A51701Q54664102-0E7146ED-0E7B-434A-8199-8EB7335D531F
P2860
The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The mesopancreas is the primar ...... relevance for clinical trials.
@en
The mesopancreas is the primar ...... relevance for clinical trials.
@nl
type
label
The mesopancreas is the primar ...... relevance for clinical trials.
@en
The mesopancreas is the primar ...... relevance for clinical trials.
@nl
prefLabel
The mesopancreas is the primar ...... relevance for clinical trials.
@en
The mesopancreas is the primar ...... relevance for clinical trials.
@nl
P2093
P2860
P1476
The mesopancreas is the primar ...... relevance for clinical trials.
@en
P2093
B M Ghadimi
P2860
P2888
P304
P356
10.1007/S00423-009-0494-8
P407
P577
2009-05-06T00:00:00Z